HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYN

Hummingbird TTS ear tube system expanded for use in young children

The Hummingbird TTS will make ear procedures much less complicated and expensive, and it is now cleared for children aged 6 months and above.

The surgical technology company Preceptis Medical recently announced US Food and Drug Administration clearance for expanded uses of the Hummingbird® Tympanostomy Tube System (TTS). This will allow in-office procedures in children aged 6 months and above.

The Hummingbird TTS is used for pediatric ear tube procedures, combining the steps and tools of a standard procedure into a single device. This allows otolaryngologists or ear, nose, and throat specialists (ENTs) in an office setting to make an incision and deliver an ear tube with a single pass. Fasting, general anesthesia, and an operating room will not be necessary with the Hummingbird, which has a 98% success rate in an office environment. Parents can also be present, and only topical anesthetic will be necessary.

“This device has been a gamechanger for patients and families. Having their child’s ear tubes placed in a quick office visit is comforting to parents, and they have been happy with the results. We look forward to offering this procedure to even more eligible patients,” said Nathan Page, MD, pediatric otolaryngologist at Phoenix Children’s Hospital.

The Hummingbird could save thousands of dollars per patient, across about one million children that undergo ear tube procedures a year. Launch plans from Preceptis Medical were a success, and the company will continue this momentum to expand accessibility of the Hummingbird even further.

“Our goal when we started Preceptis was to provide a safe, simple, and less expensive ear tube procedure option to all families. This final label expansion represents the work of many ENTs, clinical study coordinators, and team members, and I appreciate the trust parents put into Preceptis and our ENTs while participating in the study,” said Steve Anderson, CEO, Preceptis Medical.

Reference

Preceptis Medical receives FDA clearance for expanded labeling for Hummingbirdsystem. Business Wire. August 15, 2022. Accessed August 18, 2022. https://www.businesswire.com/news/home/20220815005100/en/Preceptis-Medical-Receives-FDA-Clearance-for-Expanded-Labeling-for-Hummingbird-System